A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
University of Nebraska
University of California, San Diego
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
St. Petersburg State Pavlov Medical University
Beijing 302 Hospital
University of Nebraska
Wake Forest University Health Sciences
University of Nebraska
First Affiliated Hospital of Zhejiang University
University of Liege
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Mesoblast, Ltd.
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)